This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Sandra M. Brown, MD; David W. Lamberts, MD; Ted W. Reid, PhD
Lubbock, Tex

Teruo Nishida, MD, DSc
Yamaguchi, Japan

Christopher J. Murphy, DVM, PhD
Madison, Wis

Arch Ophthalmol. 1997;115(7):926-927.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We describe the use of topical substance P (SP) and insulinlike growth factor 1 (IGF-1) in the treatment of severe neurotrophic and anhidrotic keratopathy in a young child. These compounds may provide a medical therapy for patients with keratopathy due to corneal anesthesia or dry eyes unresponsive to lubrication.

Report of a Case.

A 16-month-old white girl was referred to 1 of us (D.W.L.) for the evaluation of bilateral nonhealing corneal epithelial defects. She had difficulty swallowing since birth and developmental delay. She never produced tears when crying. An ocular examination revealed bilateral central epithelial defects (~5x5) mm) in both eyes; there was no evidence of infection or uveitis. There were no visible tear lakes. The child had no blink response to a cotton wisp or to instillation of eyedrops. Despite intensive lubrication and bandage contact lens treatment, rapid stromal melting occurred bilaterally (Figure 1), leading to a central descemetocele . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?